 |
|
|
| |
Bulevirtide Monotherapy is Safe and Well Tolerated in Chronic Hepatitis Delta:
An Integrated Safety Analysis of Bulevirtide Clinical Trials at Week 96
|
| |
| |
EASL 2026 Barcelona May 26-30
Tarik Asselah1, Soo Aleman2, Maurizia Brunetto3,4, Vladimir Chulanov5, Adrian Streinu-Cercel6,7, George Sebastian Gherlan7,8, Viacheslav Morozov9, Olga Sagalova10, Tatiana Stepanova11, Sreenivasu Yalamanchili12, Steve Tseng12, Florence Christian-Cox13, Danielle Shing13, Lei Ye12, Amos Lichtman12, Dmitry Manuilov12, Heiner Wedemeyer14, Pietro Lampertico15,16
|
| |
|
|
|
|
|
